# Chimeric antigen receptor (CAR)-T-cell therapy in non-small-cell lung cancer (NSCLC): current status and future perspectives

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/chimeric-antigen-receptor-car-t-cell-therapy-in-non-small-cell-lung-cancer-nsclc/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jingjing Qu,Quanhui Mei,Lijun Chen,Jianying Zhou |
| Citations | 141 |
| DOI | 10.1007/s00262-020-02735-0 |
| Fields | Engineering,Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://link.springer.com/content/pdf/10.1007/s00262-020-02735-0.pdf |
| OpenAlex ID | https://openalex.org/W3092177501 |
| PMID | 33025047 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Jingjing Qu](https://scholariq.org/researchers/jingjing-qu/)

## Paper primary topic

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

## Paper topics

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Silicon Carbide Semiconductor Technologies](https://scholariq.org/topics/silicon-carbide-semiconductor-technologies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.